{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T21:03:27Z","timestamp":1769720607924,"version":"3.49.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.vaccine.2013.03.044","type":"journal-article","created":{"date-parts":[[2013,12,10]],"date-time":"2013-12-10T05:17:10Z","timestamp":1386652630000},"page":"K21-K27","source":"Crossref","is-referenced-by-count":13,"special_numbering":"S10","title":["A systematic review of validated methods to capture several rare conditions using administrative or claims data"],"prefix":"10.1016","volume":"31","author":[{"given":"Christopher D.","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Elizabeth","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nila A.","family":"Sathe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa L.","family":"McPheeters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"January (Suppl. 1)","key":"10.1016\/j.vaccine.2013.03.044_bib0005","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/pds.2323","article-title":"The Food and Drug Administration's Post-Licensure Rapid Immunization Safety Monitoring program: strengthening the federal vaccine safety enterprise","volume":"21","author":"Nguyen","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"April (18)","key":"10.1016\/j.vaccine.2013.03.044_bib0010","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1016\/j.vaccine.2012.02.057","article-title":"Health outcomes of interest for evaluation in the Post-Licensure Rapid Immunization Safety Monitoring Program","volume":"30","author":"Lieu","year":"2012","journal-title":"Vaccine"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2013.03.044_bib0015","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1177\/0883073812455104","article-title":"Acute disseminated encephalomyelitis","volume":"27","author":"Alper","year":"2012","journal-title":"J Child Neurol"},{"key":"10.1016\/j.vaccine.2013.03.044_bib0020","doi-asserted-by":"crossref","unstructured":"El-Dairi MA, Ghasia F, Bhatti MT. Pediatric optic neuritis. Int Ophthalmol Clin 2012 Summer;52(3):29\u201349, xii.","DOI":"10.1097\/IIO.0b013e318259dec6"},{"key":"10.1016\/j.vaccine.2013.03.044_bib0025","first-page":"CD001430","article-title":"Corticosteroids for treating optic neuritis","volume":"4","author":"Gal","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.vaccine.2013.03.044_bib0030","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/B978-0-444-52014-2.00046-X","article-title":"Tourette syndrome and other tic disorders","volume":"100","author":"Singer","year":"2011","journal-title":"Handb Clin Neurol"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2013.03.044_bib0035","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.pcl.2012.03.013","article-title":"Pediatric vasculitis","volume":"59","author":"Weiss","year":"2012","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.vaccine.2013.03.044_bib0040","unstructured":"McPheeters M, Sathe N, Jerome R, Carnahan R. Methods for systematic reviews of administrative database studies capturing health outcomes of interest vaccine (in review)."},{"issue":"January (Suppl. 1)","key":"10.1016\/j.vaccine.2013.03.044_bib0045","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/pds.2321","article-title":"Mini-Sentinel's systematic reviews of validated methods for identifying health outcomes using administrative and claims data: methods and lessons learned","volume":"21","author":"Carnahan","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2013.03.044_bib0050","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/01.inf.0000133048.75452.dd","article-title":"Acute disseminated encephalomyelitis in childhood: epidemiologic, clinical and laboratory features","volume":"23","author":"Leake","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"September (12)","key":"10.1016\/j.vaccine.2013.03.044_bib0055","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1212\/WNL.0b013e31822facdd","article-title":"Incidence of acquired CNS demyelinating syndromes in a multiethnic cohort of children","volume":"77","author":"Langer-Gould","year":"2011","journal-title":"Neurology"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2013.03.044_bib0060","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ajo.2012.06.023","article-title":"Initiation of anti-TNF therapy and the risk of optic neuritis; from the safety assessment of biologic therapy (SABER) Study","volume":"155","author":"Winthrop","year":"2013","journal-title":"Am J Ophthalmol"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2013.03.044_bib0065","first-page":"CR160","article-title":"A two-phased population epidemiological study of the safety of thimerosal-containing vaccines: a follow-up analysis","volume":"11","author":"Geier","year":"2005","journal-title":"Med Sci Monit"},{"issue":"August (1\u20132)","key":"10.1016\/j.vaccine.2013.03.044_bib0070","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jns.2008.04.002","article-title":"Thimerosal exposure in infants and neurodevelopmental disorders: an assessment of computerized medical records in the Vaccine Safety Datalink","volume":"271","author":"Young","year":"2008","journal-title":"J Neurol Sci"},{"issue":"November (5)","key":"10.1016\/j.vaccine.2013.03.044_bib0075","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1542\/peds.112.5.1039","article-title":"Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases","volume":"112","author":"Verstraeten","year":"2003","journal-title":"Pediatrics"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2013.03.044_bib0080","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1097\/CHI.0b013e3181825a3d","article-title":"Neuropsychiatric disorders associated with streptococcal infection: a case-control study among privately insured children","volume":"47","author":"Leslie","year":"2008","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"August (2)","key":"10.1016\/j.vaccine.2013.03.044_bib0085","doi-asserted-by":"crossref","first-page":"e325","DOI":"10.1542\/peds.2009-3195","article-title":"Henoch-Scholein purpura and polysaccharide meningococcal vaccine","volume":"126","author":"Goodman","year":"2010","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.vaccine.2013.03.044_bib0090","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000314345","article-title":"Door-to-door survey of major neurological disorders in Al Kharga District, New Valley, Egypt: methodological aspects","volume":"35","author":"El Tallawy","year":"2010","journal-title":"Neuroepidemiology"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2013.03.044_bib0095","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1600-0404.1996.tb00043.x","article-title":"Incidence and lifetime prevalence of Bell's palsy in two Sicilian municipalities. Sicilian Neuro-Epidemiologic Study (SNES) Group","volume":"94","author":"Savettieri","year":"1996","journal-title":"Acta Neurol Scand"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2013.03.044_bib0100","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/mus.23261","article-title":"Hospital discharge database optimization in Guillain-Barre syndrome surveillance","volume":"46","author":"Lee","year":"2012","journal-title":"Muscle Nerve"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13003812?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13003812?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,19]],"date-time":"2022-03-19T11:27:34Z","timestamp":1647689254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13003812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":20,"alternative-id":["S0264410X13003812"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.03.044","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}